Drug intelligence / Profile preview

Fentanyl Sandoz

Development stage
Unknown
Lead developer
Sandoz
Modality
Small Molecules
Administration
Transdermal
01

Overview

Fentanyl Sandoz is a transdermal patch formulation of the potent opioid analgesic fentanyl, developed as a generic version of the reference product Duragesic. It is indicated for the management of chronic severe pain, including cancer-related pain, in opioid-tolerant patients who require continuous, around-the-clock analgesia. The product utilizes a matrix-based delivery system to provide sustained systemic delivery of fentanyl over a 72-hour period following application to intact skin. Fentanyl acts primarily as a potent agonist at the mu-opioid receptors in the central nervous system, inhibiting ascending pain pathways and altering the perception of and response to pain. Sandoz has demonstrated the therapeutic equivalence of its patch through bioequivalence studies comparing it to the reference listed drug.

Brand names
Sandoz FentanylFentanyl Sandoz
Other names
Fentanyl patch SandozFentanyl transdermal delivery system Sandoz
02

Targets

MOR (Mu opioid receptor)DOR (Opioid Receptor Delta 1)KOR (Kappa opioid receptor)

Beyond the preview

Go deeper on Fentanyl Sandoz.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fentanyl Sandoz.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call